• MilliporeSigma Granted 20 CRISPR Patents Total Worldwide americanpharmaceuticalreview
    August 21, 2019
    MilliporeSigma, a leader in genome editing, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing MilliporeSigma's patent application claims covering CRISPR gene-editing technol
PharmaSources Customer Service